Evaluation of the Safety of Quetiapine in Treating Delirium in Critically Ill Children: A Retrospective Review
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Quetiapine is an atypical antipsychotic that has been used off-label for the treatment of intensive care unit (ICU) delirium in the adult population, with studies demonstrating both efficacy and a favorable safety profile. Although there is a potential role for quetiapine in the treatment of pediatric ICU delirium, there has been no systematic reporting to date of safety in this patient population. METHODS: Pharmacy records were used to identify 55 consecutive pediatric ICU patients who were diagnosed with delirium and received quetiapine. A comprehensive retrospective medical chart review was performed to collect data on demographics, dosing, and side effects. RESULTS: Fifty patients treated between January 2013 and November 2014 were included, and five patients were excluded from the study. Subjects ranged in age from 2 months to 20 years. Median daily dose was 1.3 mg/kg/day, and median duration of treatment was 12 days. There were three episodes of QTc prolongation that were clinically nonsignificant with no associated dysrhythmia: Two resolved over time without intervention, and one resolved with decrease in quetiapine dosage. There were no episodes of extrapyramidal symptoms or neuroleptic malignant syndrome. CONCLUSIONS: In this population of critically ill youth, short-term use of quetiapine as treatment for delirium appears to be safe, without serious adverse events. Further research is required to assess efficacy and evaluate for long-term effects. A prospective, randomized, placebo-controlled study of quetiapine in managing pediatric delirium is necessary.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation
Pavlov, V. A., Wang, H., Czura, C. J., Friedman, S. G., & Tracey, K. J. (2003) · Molecular Medicine · doi:10.1007/bf03402177 · Cited by 772 · cited 1×
“Multiple central nervous system pathways have been implicated in the development of delirium, including dopaminergic, serotoninergic, glutaminergic, and cholinergic pathways in the cerebral cortex, striatum, substantia nigra, and thalamus (Pavlov et al. 2003; Gunther et al. 2008).”
van den Boogaard, M., Schoonhoven, L., Evers, A. W. M., van der Hoeven, J. G., van Achterberg, T., & Pickkers, P. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e31822e9fc9 · Cited by 361 · cited 1×
“…care unit (ICU) delirium is associated with higher mortality, long-term cognitive impairment, and dramatically higher medical costs (Milbrandt et al. 2004; Pisani et al. 2009; Girard et al. 2010; Saczynski et al. 2012; Van den Boogaard et al. 2012; Barr et al. 2013; Klein Klouwenberg et al. 2014).”
Atypical Antipsychotic Medications to Control Symptoms of Delirium in Children and Adolescents
Turkel, S. B., Jacobson, J., Munzig, E., & Tavaré, C. J. (2012) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2011.0084 · Cited by 80 · cited 2×
“When these interventions are not sufficient, pharmacologic management of delirium symptoms may be indicated (Meagher 2001; Turkel et al. 2012; Turkel and Hanft 2014).”
The Pharmacologic Management of Delirium in Children and Adolescents
Turkel, S. B., & Hanft, A. (2014) · Pediatric Drugs · doi:10.1007/s40272-014-0078-0 · Cited by 64 · cited 1×
“When these interventions are not sufficient, pharmacologic management of delirium symptoms may be indicated (Meagher 2001; Turkel et al. 2012; Turkel and Hanft 2014).”
Cited by
Smith, H. A. B., Besunder, J. B., Betters, K. A., Johnson, P. N., Srinivasan, V., Stormorken, A., Farrington, E., Golianu, B., Godshall, A. J., Acinelli, L., et al. (2022) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0000000000002873 · Cited by 505
Self-citationDelirium and Mortality in Critically Ill Children: Epidemiology and Outcomes of Pediatric Delirium
Traube, C., Silver, G., Gerber, L. M., Kaur, S., Mauer, E. A., Kerson, A., Joyce, C., & Greenwald, B. M. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002324 · Cited by 379
Delirium in Pediatric Critical Care
Patel, A. K., Bell, M. J., & Traube, C. (2017) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2017.06.009 · Cited by 122
Self-citationPediatric Delirium: Evaluation, Management, and Special Considerations
Malas, N., Brahmbhatt, K., McDermott, C., Smith, A., Ortiz-Aguayo, R., & Turkel, S. (2017) · Current Psychiatry Reports · doi:10.1007/s11920-017-0817-3 · Cited by 67
Pediatric Delirium: Recognition, Management, and Outcome
Turkel, S. B. (2017) · Current Psychiatry Reports · doi:10.1007/s11920-017-0851-1 · Cited by 58
Metadata
- Authors
- Joyce, C., Witcher, R., Herrup, E., Kaur, S., Mendez-Rico, E., Silver, G., Greenwald, B. M., & Traube, C.
- Venue
- Journal of Child and Adolescent Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2015-11
- Volume
- 25
- Issue
- 9
- Pages
- 666-670
- ISSN
- 1044-5463 (ISSN-L)
- 1557-8992
- OpenAlex
- W2153124585
- Cited by
- 100
- References
- 4
- FWCI
- 5.79
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.